D K Tadaki
Overview
Explore the profile of D K Tadaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gage F, Leeser D, Porterfield N, Graybill J, Gillern S, Hawksworth J, et al.
Transplant Proc
. 2009 Nov;
41(9):3571-4.
PMID: 19917346
This pilot study compared the use of the Lifor Organ Preservation Medium (RTLF) at room temperature with hypothermic Belzer machine preservation solution (CMPS) and room in vitro temperature Belzer machine...
2.
Hawksworth J, Elster E, Fryer D, Sheppard F, Morthole V, Krishnamurthy G, et al.
J Thromb Haemost
. 2009 Aug;
7(10):1663-71.
PMID: 19656278
Introduction: Human lyophilized platelets hold promise as a novel hemostatic infusion agent for the control of traumatic hemorrhage. Rehydrated, lyophilized platelets (Stasix) were investigated as an infusible hemostatic agent in...
3.
Porcine CD80: cloning, characterization, and evidence for its role in direct human T-cell activation
Tadaki D, Williams A, Lee K, Kirk A, Harlan D
Xenotransplantation
. 2003 Apr;
10(3):252-8.
PMID: 12694545
Previous studies has shown that human anti-pig reactivity in mixed lymphocyte cultures require the indirect presentation of antigens by human antigen presenting cells (APC). Xenoreactivity was inhibited by blockade of...
4.
Xu H, Arnaud F, Tadaki D, Burkly L, Harlan D, Kirk A
Transplantation
. 2001 Dec;
72(11):1858-61.
PMID: 11740405
Background: Delayed xenograft rejection is associated with endothelial cell activation, platelet sequestration, and subsequent thrombosis. We evaluated whether human platelets could directly activate porcine endothelium (PEC), and if so, whether...
5.
Elster E, Xu H, Tadaki D, Montgomery S, Burkly L, Berning J, et al.
Transplantation
. 2001 Nov;
72(9):1473-8.
PMID: 11707732
Background: Allogeneic skin transplantation remains a rigorous test of any immune intervention designed to prevent allograft rejection. To date, no single, clinically available immunosuppressant has been reported to induce long-term...
6.
Kirk A, Tadaki D, Celniker A, Batty D, Berning J, Colonna J, et al.
Transplantation
. 2001 Aug;
72(3):377-84.
PMID: 11502964
CD80 and CD86 (also known as B7-1 and B7-2, respectively) are both ligands for the T cell costimulatory receptors CD28 and CD152. Both CD80 and CD86 mediate T cell costimulation,...
7.
Kirk A, Blair P, Tadaki D, Xu H, Harlan D
Philos Trans R Soc Lond B Biol Sci
. 2001 May;
356(1409):691-702.
PMID: 11375072
CD154 plays a critical role in determining the outcome of a transplanted organ. This simple statement is amply supported by experimental evidence demonstrating that anti-CD154 antibodies are potent inhibitors of...
8.
Elster E, Xu H, Tadaki D, Burkly L, Berning J, Baumgartner R, et al.
Transplant Proc
. 2001 Mar;
33(1-2):675-6.
PMID: 11267012
No abstract available.
9.
Tadaki D, Craighead N, Saini A, Celniker A, Burkly L, Lee K, et al.
Transplantation
. 2000 Aug;
70(1):162-7.
PMID: 10919595
Background: T-cell costimulatory blocking agents inhibit allospecific T-cell responses in vitro and prevent allograft rejection in vivo. Costimulatory requirements for discordant xenospecific cellular responses remain undefined. We have evaluated costimulatory...
10.
Blair P, Riley J, Harlan D, Abe R, Tadaki D, Hoffmann S, et al.
J Exp Med
. 2000 Feb;
191(4):651-60.
PMID: 10684857
Signals generated through CD28-B7 and CD40 ligand (CD40L)-CD40 interactions have been shown to be crucial for the induction of long-term allograft survivability. We have recently demonstrated that humanized anti-CD40L (hu5C8)...